SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-028639
Filing Date
2022-05-20
Accepted
2022-05-20 17:29:21
Documents
14
Period of Report
2022-05-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160408-8k_bimiinter.htm   iXBRL 8-K 27156
2 PRESS RELEASE DATED MAY 20, 2022 ea160408ex99-1_bimiinter.htm EX-99.1 153277
  Complete submission text file 0001213900-22-028639.txt   407089

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20220520.xsd EX-101.SCH 3200
4 XBRL DEFINITION FILE bimi-20220520_def.xml EX-101.DEF 26192
5 XBRL LABEL FILE bimi-20220520_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE bimi-20220520_pre.xml EX-101.PRE 24850
8 EXTRACTED XBRL INSTANCE DOCUMENT ea160408-8k_bimiinter_htm.xml XML 4441
Mailing Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100
Business Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100 (8604) 1182209211
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 22948899
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries